CNSP
CNS Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
CNSP fundamentals
CNS Pharmaceuticals (CNSP) released its earnings on Aug 14, 2025: revenue was -- (YoY --), beat estimates; EPS was -6.42 (YoY +99.84%), beat estimates.
Revenue / YoY
--
--
EPS / YoY
-6.42
+99.84%
Report date
Aug 14, 2025
EPS
Actual | -108000 | -135000 | -126000 | -81000 | -111300 | -77700 | -32400 | -4032 | -150 | -447.96 | -18.96 | -6.42 | ||||
Forecast | -108000 | -117000 | -120000 | -144000 | -54000 | -72000 | -51900 | -57000 | -60 | -87.96 | -24 | -9.6 | ||||
Surprise | 0.00% | 0.00% | -15.38% | -5.00% | 0.00% | -50.00% | -54.58% | 0.00% | +37.57% | 0.00% | 0.00% | 0.00% | -150.00% | -409.28% | +21.00% | +33.13% |
Revenue
Actual | -- | 0 | 0 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Forecast | -- | 0 | 0 | 0 | 0 | 0 | 0 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What guidance did CNS Pharmaceuticals's management provide for the next earnings period?What is the revenue and EPS growth rate for CNS Pharmaceuticals year over year?What is CNS Pharmaceuticals's latest dividend and current dividend yield?What is the market's earnings forecast for CNS Pharmaceuticals next quarter?What does CNS Pharmaceuticals do and what are its main business segments?What were the key takeaways from CNS Pharmaceuticals's earnings call?Did CNS Pharmaceuticals beat or miss consensus estimates last quarter?What were the key takeaways from CNS Pharmaceuticals’s earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
